Clinical and laboratory features of systemic lupus erythematosus (SLE) in Pakistani patients

Journal of the Pakistan Medical Association

Volumn 52, Issue 1, 2002, Pages 12-15

  Ahmed, T A ^b   Ikram, N ^a   Hussain, T ^a   Farooqui, A ^a   Haleem, A ^a   Bashir, M ^a   Moin, S ^c   Karamat, K A ^a  

^a ARMED FORCES INSTITUTE OF PATHOLOGY   (Pakistan)

^b Military Hospital (MH)   (Pakistan)

^c PAKISTAN INSTITUTE OF MEDICAL SCIENCES   (Pakistan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CHI SQUARE DISTRIBUTION; CHILD; CLINICAL TRIAL; FEMALE; HUMAN; MALE; MULTICENTER STUDY; PAKISTAN; PRESCHOOL CHILD; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; CHI-SQUARE DISTRIBUTION; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; PAKISTAN;

EID: 0036372469     PISSN: 00309982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Isenberg DA. Systemic lupus erythematosus: immunopathogenesis and the card game analogy. J. Rheumatol., 1997:24:62 - 6.
2. Hey EM, Snaith ML. Systemic lupus erythematosus and lupus like syndromes. Br. Med. J., 1995:2: 129-33.
3. Snaith ML, Isenberg DA. In: Systemic lupus erythematosus and related disorders. Weatherall D.J, Ledingham J.G.G, Werrell D.A (eds.). Oxford textbook of medicine. NewYork: Oxford. 1996:pp.3017-27.
4. Schur P.H. Systemic lupus erythematosus: In: Bennet J.C, Plum.F.(eds.). Cecil textbook of medicine.Philadelphia. W. B. Saunders, 1996:pp.1475 - 83.
5. Smolen JS, Steiner G, Tan EM. Standards of care: the value and importance of standardization. Arthritis and Rheumatism 1997:40:410 - 2.
6. Tan EM, Cohen AS, Fries JF,et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis and Rheumatism 1982:25:1271 - 77.
7. Tan EM, Feltkamp TEW, Smolen JS, et al. Range of Antinuclear antibody in "Healthy" individuals. Arthritis and Rheumatism 1997:40:1601 - 11.
8. Anwar F, Azama AMA, Mandourah A, et al. Fluorescent antinuclear antibody and antidouble stranded DNA antibody testing: a four year experience. J. Pak. Med. Assoc., 1997:47:226 - 8.
9. Hahn BH. Antibodies to DNA. New. Engl. J. Med., 1998:338: 1359-68.
10. Ahmed TA, Malik IA, Saleem M, et al. Antibodies to the extractable Nuclear antigens(ENA) in Pakistani patients with Systemic Rheumatic Disease. J. Pak. Med. Assoc., 1995:45:12 - 14.
11. Ismail A.A, Snowden N. Autoantibodies as specific serum proteins in the diagnosis of rheumatological disorders. Ann. Clin. Biochem., 1999: 36:565 - 78.
12. Rowell NR, Goodfield MJD. The connective tissue diseases. In: Champion RH, Burton JL, Burns DA, Breathnach SM. (eds.). Textbook of dermatology. London:Blackwell Science Ltd. 1998:2437-2500.
13. Klippel JH. Predicting who will get lupus nephritis. J. Clin. Rheumatol., 1995:1:257 - 9.
14. Feltkamp TEW. Antinuclear antibody determination in a routine Laboratory. Ann. Rheum. dis., 1996:55:723 - 7.
15. Harley J.B. Autoantibodies are central to the diagnosis and clinical manifestation of lupus. J. Rheum., 1994:21:1183 - 5.
16. Sox HC, Liang MH, Stanford AP. The erythrocyte sedimentation rate. guidelines for rational use. Annals. Inter. Med., 1986:104: 515 - 23.
17. Borg EJ, Horst G, Limburg PC, et al. Creactive protein levels during disease exacerbations and infections in systemic lupus erythematosus: a prospective longitudinal study. J. Rheum., 1990:17:1642 - 8.